Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: REVVITY HEALTH SCIENCES, INC.
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2018-09-07 to 2023-09-30
Current total value of award: $33278
Description: VASOPRESSIN FOR TAMC, HI - EXERCISE OPTION IV, 1 OCT 2022 - 30 SEP 2023